92 related articles for article (PubMed ID: 3280345)
1. Renin inhibitors. Improvements in the stability and biological activity of small peptides containing novel Leu-Val replacements.
Kleinert HD; Luly JR; Marcotte PA; Perun TJ; Plattner JJ; Stein H
FEBS Lett; 1988 Mar; 230(1-2):38-42. PubMed ID: 3280345
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
3. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
[TBL] [Abstract][Full Text] [Related]
4. Potent renin inhibitory peptides containing hydrophilic end groups.
Bundy GL; Pals DT; Lawson JA; Couch SJ; Lipton MF; Mauragis MA
J Med Chem; 1990 Aug; 33(8):2276-83. PubMed ID: 2197413
[TBL] [Abstract][Full Text] [Related]
5. New modified heterocyclic phenylalanine derivatives. Incorporation into potent inhibitors of human renin.
Ocain TD; Deininger DD; Russo R; Senko NA; Katz A; Kitzen JM; Mitchell R; Oshiro G; Russo A; Stupienski R
J Med Chem; 1992 Mar; 35(5):823-32. PubMed ID: 1548674
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites.
Kaltenbronn JS; Hudspeth JP; Lunney EA; Michniewicz BM; Nicolaides ED; Repine JT; RoarK WH; Stier MA; Tinney FJ; Woo PK
J Med Chem; 1990 Feb; 33(2):838-45. PubMed ID: 2405159
[TBL] [Abstract][Full Text] [Related]
7. New inhibitors of human renin that contain novel Leu-Val replacements.
Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
[TBL] [Abstract][Full Text] [Related]
8. Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement.
Dellaria JF; Maki RG; Bopp BA; Cohen J; Kleinert HD; Luly JR; Merits I; Plattner JJ; Stein HH
J Med Chem; 1987 Nov; 30(11):2137-44. PubMed ID: 3118024
[TBL] [Abstract][Full Text] [Related]
9. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements.
Dellaria JF; Maki RG; Stein HH; Cohen J; Whittern D; Marsh K; Hoffman DJ; Plattner JJ; Perun TJ
J Med Chem; 1990 Feb; 33(2):534-42. PubMed ID: 2105396
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
[TBL] [Abstract][Full Text] [Related]
11. Competitive inhibitors of renin. A review.
Poulsen K; Burton J; Haber E
Prog Biochem Pharmacol; 1976; 12():135-41. PubMed ID: 14338
[TBL] [Abstract][Full Text] [Related]
12. NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART III.
Marszałek D; Goldnik A; Winiecka I; Jaworski P; Mazurek AP
Acta Pol Pharm; 2016; 73(2):329-36. PubMed ID: 27180425
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo.
Thaisrivongs S; Pals DT; Harris DW; Kati WM; Turner SR
J Med Chem; 1986 Oct; 29(10):2088-93. PubMed ID: 3531518
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
15. Highly potent and specific inhibitors of human renin.
Sham HL; Stein H; Rempel CA; Cohen J; Plattner JJ
FEBS Lett; 1987 Aug; 220(2):299-301. PubMed ID: 3111889
[TBL] [Abstract][Full Text] [Related]
16. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives.
Bradbury RH; Major JS; Oldham AA; Rivett JE; Roberts DA; Slater AM; Timms D; Waterson D
J Med Chem; 1990 Sep; 33(9):2335-42. PubMed ID: 2118184
[TBL] [Abstract][Full Text] [Related]
17. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
[TBL] [Abstract][Full Text] [Related]
18. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
